Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Class action filed Acq. announced Consulting agrmnt Quarterly results Director departure Appointed director CC transcript
|
ERESEARCHTECHNOLOGY INC (ERES)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/09/2012 |
8-K
| Quarterly results |
07/09/2012 |
8-K
| Entered into consulting agreement
Docs:
|
"Agreement and Plan of Merger, by and among invivodata, Inc., Explorer Holdings, Inc., eResearchTechnology, Inc. (as successor to Explorer Acquisition Corp.), Impact Acquisition Corp. and Fortis Advisors LLC",
"Amended and Restated Certificate of Incorporation of eResearchTechnology, Inc",
"Amended and Restated Bylaws of eResearchTechnology, Inc",
"Genstar Capital Completes ERT Acquisition In A Take-Private Transaction PHILADELPHIA, July 3, 2012/PRNewswire/—ERT , a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations , announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction valued at approximately $400 million. Dr. Jeffrey Litwin, who will continue to lead ERT as CEO, said, “As a private company we will continue to serve our customers and enhance our suite of products. We have been able to grow our company into a global leader, and, with Genstar's partnership, we will look for creative new ways to grow our business organically and identify new investment opportunities as part of our continued develo...",
"ERT Acquires invivodata to Establish the Industry's Most Experienced Provider of Clinical Outcome Assessment Solutions PHILADELPHIA, PA, July 9 2012 /PRNewswire/ - ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and Contract Research Organizations , announced today the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes solutions and PRO Consulting services, based in Pittsburgh, PA. The transaction was facilitated by the San Francisco-based private equity group, Genstar Capital, LLC who last week announced that they had completed the acquisition of ERT. The acquisition immediately positions ERT as a leader in Clinical Outcome Assessments . The combined organization will now offer sponsors, CROs and ot..." |
|
06/12/2012 |
8-K
| Class action lawsuit filed |
05/07/2012 |
8-K
| Quarterly results |
05/04/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
04/10/2012 |
8-K
| Form 8-K - Current report |
03/01/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/27/2012 |
8-K
| Quarterly results |
02/06/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
10/27/2011 |
8-K
| Form 8-K - Current report |
08/01/2011 |
8-K
| Form 8-K - Current report |
05/02/2011 |
8-K
| Form 8-K - Current report |
04/22/2011 |
8-K
| Form 8-K - Current report |
03/01/2011 |
8-K
| Form 8-K - Current report |
12/21/2010 |
8-K
| Form 8-K - Current report |
11/04/2010 |
8-K
| Quarterly results |
09/16/2010 |
8-K
| Form 8-K - Current report |
08/09/2010 |
8-K
| Form 8-K - Current report |
08/05/2010 |
8-K/A
| Financial Statements and Exhibits
Docs:
|
"Consent of Independent Registered Public Accounting Firm — Ernst & Young GmbH",
"Audited combined balance sheets of Research Services (a division of CareFusion Corporation comprised of the research services division of CareFusion Germany 234 GmbH and certain research operations of CareFusion Corporation) as of December 31, 2009 and 2008, and the related audited combined statements of income, cash flows and parent company equity for each of the two years in the period ended December 31, 2009, together with the report of Ernst & Young, GmbH",
"Condensed combined balance sheets of Research Services (a division of CareFusion Corporation comprised of the research services division of CareFusion Germany 234 GmbH and certain research operations of CareFusion Corporation) as of March 31, 2010 (unaudited) and December 31, 2009, and the related unaudited condensed combined statements of operations and cash flows for the three months ended March 31, 2010 and 2009",
"Unaudited pro forma condensed combined balance sheet of the Company and its subsidiaries as of March 31, 2010, and the related unaudited pro forma condensed combined statements of operations for the year ended December 31, 2009 and the three months ended March 31, 2010" |
|
06/03/2010 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs:
|
"Credit Agreement between eResearchTechnology, Inc. and Citizens Bank of Pennsylvania",
"Revolver Note made by eResearchTechnology, Inc. payable to the order of Citizens Bank of Pennsylvania",
"Guaranty by ERT Tech Corporation, ERT Investment Corporation, Covance Cardiac Safety Services Inc. and eResearchTechnology, Inc. in favor of Citizens Bank of Pennsylvania",
"Charge Over Shares and Securities between eResearchTechnology, Inc. and Citizens Bank of Pennsylvania",
"First Amendment to the Agreement Relating to the Sale, Purchase and Transfer of All Shares of Research Services Germany 234 GmbH between CareFusion Germany 234 GmbH and Blitz F10-acht-drei-fünf GmbH & Co. KG",
"ERT Closes the Acquisition of the Research Services Division of CareFusion Corporation PHILADELPHIA, June 1, 2010/PRNewswire-FirstCall/ — eResearchTechnology, Inc. , , a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, announced the successful closing of the acquisition of the Research Services Division of CareFusion Corporation . CRS is a leading provider of respiratory diagnostics services and manufacturer of diagnostic devices and also offers cardiac safety and ePRO services. The combined company offers a market leading position in the very attractive clinical research market for cardiac safety services, cardiac safety consulting, respiratory services, ePRO services, and medical devices. The acquisition will serve to diversi..." |
|
04/30/2010 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
04/29/2010 |
8-K
| Quarterly results
Docs:
|
"ERT Reports First Quarter 2010 Results Conference Call to Discuss Acquisition and First Quarter Results of Operations to be held on April 29, 2010 at 5:00 PM EDT PHILADELPHIA, April 29, 2010/PRNewswire-FirstCall/ — eResearchTechnology, Inc. , , a global provider of technology and services to the pharmaceutical, biotechnology, and medical device industries, announced today results for the first quarter ended March 31, 2010. Unless otherwise noted, all comparative numbers refer to changes from the same period a year ago. A conference call to discuss these results will be held on April 29, 2010 at 5:00 PM EDT. Financial highlights for the first quarter of 2010:" |
|
03/19/2010 |
8-K
| Form 8-K - Current report |
02/25/2010 |
8-K
| Form 8-K - Current report |
10/29/2009 |
8-K
| Form 8-K - Current report |
07/30/2009 |
8-K
| Form 8-K - Current report |
06/23/2009 |
8-K
| Asset disposition |
04/30/2009 |
8-K
| Form 8-K -- Current report |
03/02/2009 |
8-K
| Form 8-K -- Current report |
02/26/2009 |
8-K
| Quarterly results |
10/30/2008 |
8-K
| Quarterly results |
08/04/2008 |
8-K
| Quarterly results, Appointed a new director |
07/23/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ... |
07/18/2008 |
8-K
| Entry into a Material Definitive Agreement |
|
|
|